Literature DB >> 19996326

Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease.

H Liu1, R Brais, A Lavergne-Slove, Q Jeng, K Payne, H Ye, Z Liu, J Carreras, Y Huang, C M Bacon, R A Hamoudi, V Save, L Venkatraman, P G Isaacson, J Woodward, M-Q Du.   

Abstract

OBJECTIVE: An aberrant immunophenotype and monoclonality of intraepithelial lymphocytes (IELs) are frequently found in refractory coeliac disease (RCD). However, the utility of continual monitoring of IEL immunophenotype and clonality in the surveillance of RCD remains to be studied.
DESIGN: The diagnostic and follow-up biopsies from 33 patients with CD, 7 with suspected RCD, 41 with RCD and 20 with enteropathy-associated T cell lymphoma (EATL) (including 11 evolved from RCD) were investigated by CD3epsilon/CD8 double immunohistochemistry and PCR-based clonality analysis of the rearranged T cell receptor (TCR) genes.
RESULTS: An aberrant immunophenotype (CD3epsilon(+)CD8(-) IELs > or =40%) and monoclonality were detected occasionally in CD biopsies, either transiently in patients with CD not compliant with a gluten-free diet or in those who subsequently developed suspected RCD, RCD or EATL. In contrast, the aberrant immunophenotype and monoclonality were found in 30 of 41 (73%) and 24 of 37 (65%) biopsies, respectively, at the time of RCD diagnosis. Among the patients with RCD who did not show these abnormalities in their diagnostic biopsies, 8 of 10 (80%) and 5 of 11 (45%) cases gained an aberrant immunophenotype and monoclonality, respectively, during follow-up. Irrespective of whether detected in diagnostic or follow-up biopsies, persistence of both abnormalities was characteristic of RCD. Importantly, the presence of concurrent persistent monoclonality and aberrant immunophenotype, especially > or =80% CD3epsilon(+)CD8(-) IELs, was a strong predictor of EATL development in patients with RCD (p=0.001).
CONCLUSIONS: Continual monitoring of both immunophenotype and clonality of IELs is more important than snapshot analysis for RCD diagnosis and follow-up, and could provide a useful tool for surveillance of patients at risk of EATL.

Entities:  

Mesh:

Year:  2009        PMID: 19996326     DOI: 10.1136/gut.2009.186007

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

Review 1.  Classification and management of refractory coeliac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

2.  Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease.

Authors:  R L J van Wanrooij; D M J Müller; E A Neefjes-Borst; J Meijer; L G Koudstaal; D A M Heideman; H J Bontkes; B M E von Blomberg; G Bouma; C J J Mulder
Journal:  J Clin Immunol       Date:  2014-07-27       Impact factor: 8.317

3.  Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry.

Authors:  A Rubio-Tapia; G Malamut; W H M Verbeek; R L J van Wanrooij; D A Leffler; S I Niveloni; C Arguelles-Grande; B D Lahr; A R Zinsmeister; J A Murray; C P Kelly; J C Bai; P H Green; S Daum; C J J Mulder; C Cellier
Journal:  Aliment Pharmacol Ther       Date:  2016-08-03       Impact factor: 8.171

Review 4.  How to manage adult coeliac disease: perspective from the NHS England Rare Diseases Collaborative Network for Non-Responsive and Refractory Coeliac Disease.

Authors:  Elisabeth Megan Rose Baggus; Marios Hadjivassiliou; Simon Cross; Hugo Penny; Heidi Urwin; Sarah Watson; Jeremy Mark Woodward; David S Sanders
Journal:  Frontline Gastroenterol       Date:  2019-08-08

5.  Celiac disease and persistent symptoms.

Authors:  Alberto Rubio-Tapia; Susan H Barton; Joseph A Murray
Journal:  Clin Gastroenterol Hepatol       Date:  2010-08-06       Impact factor: 11.382

6.  The management of refractory coeliac disease.

Authors:  Jeremy Woodward
Journal:  Ther Adv Chronic Dis       Date:  2013-03       Impact factor: 5.091

Review 7.  Improving outcomes of refractory celiac disease - current and emerging treatment strategies.

Authors:  Jeremy Woodward
Journal:  Clin Exp Gastroenterol       Date:  2016-08-03

8.  Small bowel capsule endoscopy in refractory celiac disease: a luxury or a necessity?

Authors:  Stefania Chetcuti Zammit; Luca Elli; Lucia Scaramella; David S Sanders; Gian Eugenio Tontini; Reena Sidhu
Journal:  Ann Gastroenterol       Date:  2021-01-27

9.  A Novel Cecropin-LL37 Hybrid Peptide Protects Mice Against EHEC Infection-Mediated Changes in Gut Microbiota, Intestinal Inflammation, and Impairment of Mucosal Barrier Functions.

Authors:  Xubiao Wei; Lulu Zhang; Rijun Zhang; Matthew Koci; Dayong Si; Baseer Ahmad; Junhao Cheng; Junyong Wang; Maierhaba Aihemaiti; Manyi Zhang
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

Review 10.  Non-Responsive Coeliac Disease: A Comprehensive Review from the NHS England National Centre for Refractory Coeliac Disease.

Authors:  Hugo A Penny; Elisabeth M R Baggus; Anupam Rej; John A Snowden; David S Sanders
Journal:  Nutrients       Date:  2020-01-14       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.